questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Lipoprotéines
Lipoprotéines HDL
Lipoprotéines HDL : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Lipoprotéines HDL : Questions médicales les plus fréquentes",
"headline": "Lipoprotéines HDL : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Lipoprotéines HDL : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-02",
"dateModified": "2025-03-29",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Lipoprotéines HDL"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Lipoprotéines",
"url": "https://questionsmedicales.fr/mesh/D008074",
"about": {
"@type": "MedicalCondition",
"name": "Lipoprotéines",
"code": {
"@type": "MedicalCode",
"code": "D008074",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cholestérol HDL",
"alternateName": "Cholesterol, HDL",
"url": "https://questionsmedicales.fr/mesh/D008076",
"about": {
"@type": "MedicalCondition",
"name": "Cholestérol HDL",
"code": {
"@type": "MedicalCode",
"code": "D008076",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.479.470"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pré-bêta-lipoprotéines de haute densité",
"alternateName": "High-Density Lipoproteins, Pre-beta",
"url": "https://questionsmedicales.fr/mesh/D053442",
"about": {
"@type": "MedicalCondition",
"name": "Pré-bêta-lipoprotéines de haute densité",
"code": {
"@type": "MedicalCode",
"code": "D053442",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.479.602"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lipoprotéines HDL2",
"alternateName": "Lipoproteins, HDL2",
"url": "https://questionsmedicales.fr/mesh/D053439",
"about": {
"@type": "MedicalCondition",
"name": "Lipoprotéines HDL2",
"code": {
"@type": "MedicalCode",
"code": "D053439",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.479.735"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Lipoprotéines HDL3",
"alternateName": "Lipoproteins, HDL3",
"url": "https://questionsmedicales.fr/mesh/D053440",
"about": {
"@type": "MedicalCondition",
"name": "Lipoprotéines HDL3",
"code": {
"@type": "MedicalCode",
"code": "D053440",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.521.479.867"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Lipoprotéines HDL",
"alternateName": "Lipoproteins, HDL",
"code": {
"@type": "MedicalCode",
"code": "D008075",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Kyung-Hyun Cho",
"url": "https://questionsmedicales.fr/author/Kyung-Hyun%20Cho",
"affiliation": {
"@type": "Organization",
"name": "LipoLab, Yeungnam University, Gyeongsan 38541, Korea."
}
},
{
"@type": "Person",
"name": "Anatol Kontush",
"url": "https://questionsmedicales.fr/author/Anatol%20Kontush",
"affiliation": {
"@type": "Organization",
"name": "Unité de Recherche sur les Maladies Cardiovasculaires, Institut National de la Santé et de la Recherche Médicale (INSERM), le Métabolisme et la Nutrition, ICAN, Sorbonne Université, F-75013 Paris, France."
}
},
{
"@type": "Person",
"name": "Fernando Brites",
"url": "https://questionsmedicales.fr/author/Fernando%20Brites",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Lipids and Atherosclerosis, Department of Clinical Biochemistry, INFIBIOC, University of Buenos Aires, CONICET. Buenos Aires, Argentina."
}
},
{
"@type": "Person",
"name": "Wilfried Le Goff",
"url": "https://questionsmedicales.fr/author/Wilfried%20Le%20Goff",
"affiliation": {
"@type": "Organization",
"name": "Unité de Recherche sur les Maladies Cardiovasculaires, Institut National de la Santé et de la Recherche Médicale (INSERM), le Métabolisme et la Nutrition, ICAN, Sorbonne Université, F-75013 Paris, France."
}
},
{
"@type": "Person",
"name": "Maryam Darabi",
"url": "https://questionsmedicales.fr/author/Maryam%20Darabi",
"affiliation": {
"@type": "Organization",
"name": "National Institute for Health and Medical Research (INSERM), UMRS 1166 ICAN, Faculty of Medicine Pitié-Salpêtrière, Sorbonne University, Paris, France."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Reprogramming of Hypophosphatasia patient cells to generate a new human iPSC cell line (UOMi009-A).",
"datePublished": "2022-09-17",
"url": "https://questionsmedicales.fr/article/36152425",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.scr.2022.102921"
}
},
{
"@type": "ScholarlyArticle",
"name": "Apoptotic effects of mesenchymal stem cells' conditioned medium on colorectal cancer cell lines.",
"datePublished": "2023-10-15",
"url": "https://questionsmedicales.fr/article/37865038",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.tice.2023.102247"
}
},
{
"@type": "ScholarlyArticle",
"name": "Delivering mRNA to a human NK cell line, NK-92 cells, by lipid nanoparticles.",
"datePublished": "2023-03-08",
"url": "https://questionsmedicales.fr/article/36898618",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijpharm.2023.122810"
}
},
{
"@type": "ScholarlyArticle",
"name": "Genomic, transcriptomic and epigenomic sequencing data of the B-cell leukemia cell line REH.",
"datePublished": "2023-10-10",
"url": "https://questionsmedicales.fr/article/37817248",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13104-023-06537-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Targeting epigenetic features in clear cell sarcomas based on patient-derived cell lines.",
"datePublished": "2023-01-29",
"url": "https://questionsmedicales.fr/article/36710341",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12967-022-03843-4"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Lipoprotéines",
"item": "https://questionsmedicales.fr/mesh/D008074"
},
{
"@type": "ListItem",
"position": 5,
"name": "Lipoprotéines HDL",
"item": "https://questionsmedicales.fr/mesh/D008075"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Lipoprotéines HDL - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Lipoprotéines HDL",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Lipoprotéines HDL",
"description": "Comment mesurer le taux de HDL ?\nQuel est le taux normal de HDL ?\nQuels tests diagnostiques sont utilisés ?\nComment interpréter un faible taux de HDL ?\nLes lipoprotéines HDL sont-elles mesurables ?",
"url": "https://questionsmedicales.fr/mesh/D008075?mesh_terms=Cell+Line&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Lipoprotéines HDL",
"description": "Quels symptômes indiquent un faible HDL ?\nLe faible HDL cause-t-il des douleurs ?\nY a-t-il des signes cliniques associés ?\nUn HDL bas peut-il affecter l'énergie ?\nLe HDL bas est-il lié à d'autres maladies ?",
"url": "https://questionsmedicales.fr/mesh/D008075?mesh_terms=Cell+Line&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Lipoprotéines HDL",
"description": "Comment prévenir un faible taux de HDL ?\nLe tabagisme affecte-t-il le HDL ?\nL'alcool influence-t-il le HDL ?\nLe stress impacte-t-il le HDL ?\nLes examens réguliers sont-ils nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D008075?mesh_terms=Cell+Line&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Lipoprotéines HDL",
"description": "Comment augmenter le taux de HDL ?\nLes médicaments peuvent-ils aider ?\nQuels aliments favorisent le HDL ?\nLe HDL peut-il être traité par des suppléments ?\nLes changements de mode de vie sont-ils efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D008075?mesh_terms=Cell+Line&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Lipoprotéines HDL",
"description": "Quelles complications sont liées à un faible HDL ?\nLe HDL bas cause-t-il des AVC ?\nUn faible HDL affecte-t-il la santé mentale ?\nLe HDL bas est-il lié au diabète ?\nLe HDL bas peut-il entraîner des maladies rénales ?",
"url": "https://questionsmedicales.fr/mesh/D008075?mesh_terms=Cell+Line&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Lipoprotéines HDL",
"description": "Quels sont les principaux facteurs de risque pour un faible HDL ?\nL'âge influence-t-il le taux de HDL ?\nLe sexe affecte-t-il le HDL ?\nLe stress est-il un facteur de risque ?\nLes antécédents familiaux influencent-ils le HDL ?",
"url": "https://questionsmedicales.fr/mesh/D008075?mesh_terms=Cell+Line&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment mesurer le taux de HDL ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le taux de HDL se mesure par une analyse sanguine lipidique."
}
},
{
"@type": "Question",
"name": "Quel est le taux normal de HDL ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un taux de HDL supérieur à 1,0 g/L est considéré comme normal chez les hommes."
}
},
{
"@type": "Question",
"name": "Quels tests diagnostiques sont utilisés ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent le profil lipidique et parfois des tests génétiques."
}
},
{
"@type": "Question",
"name": "Comment interpréter un faible taux de HDL ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un faible taux de HDL augmente le risque de maladies cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Les lipoprotéines HDL sont-elles mesurables ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles sont mesurables par des tests sanguins spécifiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un faible HDL ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un faible HDL est souvent asymptomatique mais peut indiquer un risque accru de maladies cardiaques."
}
},
{
"@type": "Question",
"name": "Le faible HDL cause-t-il des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, un faible taux de HDL ne cause pas de douleurs directement."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cliniques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'y a pas de signes cliniques spécifiques liés uniquement au HDL."
}
},
{
"@type": "Question",
"name": "Un HDL bas peut-il affecter l'énergie ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un HDL bas n'affecte pas directement les niveaux d'énergie."
}
},
{
"@type": "Question",
"name": "Le HDL bas est-il lié à d'autres maladies ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un HDL bas est souvent associé à des maladies métaboliques et cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Comment prévenir un faible taux de HDL ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir un mode de vie actif et une alimentation équilibrée aide à prévenir un faible HDL."
}
},
{
"@type": "Question",
"name": "Le tabagisme affecte-t-il le HDL ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme réduit le taux de HDL, augmentant le risque cardiovasculaire."
}
},
{
"@type": "Question",
"name": "L'alcool influence-t-il le HDL ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une consommation modérée d'alcool peut augmenter le HDL, mais l'excès est nuisible."
}
},
{
"@type": "Question",
"name": "Le stress impacte-t-il le HDL ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut affecter négativement le taux de HDL."
}
},
{
"@type": "Question",
"name": "Les examens réguliers sont-ils nécessaires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des examens réguliers aident à surveiller le taux de HDL et la santé cardiovasculaire."
}
},
{
"@type": "Question",
"name": "Comment augmenter le taux de HDL ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'exercice régulier, une alimentation saine et l'arrêt du tabac peuvent augmenter le HDL."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments comme les statines peuvent aider à augmenter le HDL."
}
},
{
"@type": "Question",
"name": "Quels aliments favorisent le HDL ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les acides gras oméga-3, les noix et l'huile d'olive favorisent le HDL."
}
},
{
"@type": "Question",
"name": "Le HDL peut-il être traité par des suppléments ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains suppléments comme les oméga-3 peuvent aider à augmenter le HDL."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie sont-ils efficaces ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des changements de mode de vie peuvent significativement améliorer le taux de HDL."
}
},
{
"@type": "Question",
"name": "Quelles complications sont liées à un faible HDL ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un faible HDL est associé à un risque accru de maladies cardiaques et d'accidents vasculaires."
}
},
{
"@type": "Question",
"name": "Le HDL bas cause-t-il des AVC ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un faible taux de HDL peut augmenter le risque d'accidents vasculaires cérébraux."
}
},
{
"@type": "Question",
"name": "Un faible HDL affecte-t-il la santé mentale ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un lien entre un faible HDL et des troubles de l'humeur."
}
},
{
"@type": "Question",
"name": "Le HDL bas est-il lié au diabète ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un faible HDL est souvent observé chez les personnes diabétiques."
}
},
{
"@type": "Question",
"name": "Le HDL bas peut-il entraîner des maladies rénales ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un faible HDL peut être associé à un risque accru de maladies rénales."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque pour un faible HDL ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, le tabagisme, l'inactivité physique et une mauvaise alimentation sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le taux de HDL ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le taux de HDL tend à diminuer avec l'âge, surtout chez les femmes après la ménopause."
}
},
{
"@type": "Question",
"name": "Le sexe affecte-t-il le HDL ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes ont généralement des taux de HDL plus élevés que les hommes."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut contribuer à un faible taux de HDL."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le HDL ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies cardiovasculaires peuvent augmenter le risque de faible HDL."
}
}
]
}
]
}
In this study we report reprogramming and generation of a new human induced pluripotent stem cell line UOMi009_A, which was generated from a 64 year old male patient with childhood onset Hypophosphata...
Multipotent Mesenchymal stem cells (MSCs) have vigorous immunomodulatory activity, apoptotic effects, and the capacity to migrate to inflammatory and tumor sites. This study focuses on the apoptotic e...
In cancer immunotherapy, therapeutic methods targeting NK are highly expected. NK cell-based therapy using NK-92, a human NK cell line, has been clinically evaluated. Delivering mRNA into NK-92 cells ...
The aim of this data paper is to describe a collection of 33 genomic, transcriptomic and epigenomic sequencing datasets of the B-cell acute lymphoblastic leukemia (ALL) cell line REH. REH is one of th...
This paper describes 33 datasets corresponding to 867 gigabases of raw sequencing data generated from the REH cell line. These datasets include five different approaches for whole genome sequencing (W...
Clear cell sarcomas (CCSs) are translocated aggressive malignancies, most commonly affecting young adults with a high incidence of metastases and a poor prognosis. Research into the disease is more fe...
Isolated tumor cells and normal healthy skin fibroblasts from the same patient were compared in terms of growth behavior and morphological characteristics using light and electron microscopy. Tumorige...
The two established CCS cell lines named MUG Lucifer prim and MUG Lucifer met showed differences in morphology, genetic and epigenetic data, reflecting the respective original tissue. The detailed cel...
MUG Lucifer prim, MUG Lucifer met and isolated and immortalized fibroblasts from the same patient represent an ideal in vitro model to explore the biology of CCS. Based on this cell culture model, nov...
The present article describes a study of the effects of alpha-amylase (...
The tyrosine kinase inhibitor (TKI) cabozantinib might impede the growth of the sunitinib-resistant cell lines by targeting MET and AXL overexpression in metastatic renal cell carcinoma (mRCC). We stu...
We report the establishment of a novel activated B-cell-like (ABC) diffuse large B-cell lymphoma (DLBCL) cell line, designated as TMD12, from a patient with highly refractory DLBCL. ABC-DLBCL is a sub...
Human hepatocellular carcinoma (HCC) is the fifth most common cancer and the third leading cause of death across the world. Recent evidence suggests that STAT3 regulates proliferative, survival, metas...
Current cancer treatments damage healthy cells and tissues, causing short-term and long-term side effects. New treatments are desired that show greater selectivity toward cancer cells and evade the co...